Studies on molecular pathogenesis of BP-CML showed high level of genomic instability and additional genetic aberrations, independent of BCR-ABL1 activity [3] also in leukemic stem cells compartment [5,47]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.